48,830
edits
(→Types of rejection{{Ref WMSP|136-7}}: wikify) |
|||
Line 31: | Line 31: | ||
| acute cellular (3R) | | acute cellular (3R) | ||
| disruption of normal arch. | | disruption of normal arch. | ||
| diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & | | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & [[PMN]]s), fibre loss/damage | ||
| | | | ||
|- | |- | ||
| chronic | | chronic | ||
| concentric intimal thicking | | concentric intimal thicking | ||
| internal elastic lamina preserved (unlike atherosclerosis) | | internal elastic lamina preserved (unlike [[atherosclerosis]]) | ||
| [http://newsroom.ucla.edu/portal/ucla/srp-view.aspx?id=118724 chronic], [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig5 chronic] | | [http://newsroom.ucla.edu/portal/ucla/srp-view.aspx?id=118724 chronic], [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig5 chronic] | ||
|} | |} |
edits